Ligand-independent dimerization and activation of the oncogenic Xmrk receptor by two mutations in the extracellular

A Gómez1, C Wellbrock, H Gutbrod

  • 1Physiological Chemistry I, Biocenter (Theodor Boveri Institute), University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Insights

Activating mutations in the extracellular domain of the oncogenic receptor tyrosine kinase ONC-Xmrk drive melanoma development in Xiphophorus fish. These mutations cause constitutive dimer formation and altered receptor processing.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hereditary malignant melanoma in Xiphophorus fish originates from the overexpression of the oncogenic receptor tyrosine kinase ONC-Xmrk.
  • Proto-oncogene INV-Xmrk overexpression alone does not confer oncogenic function, indicating specific activating mutations in ONC-Xmrk are crucial.

Purpose of the Study:

  • To identify the specific activating mutations responsible for the oncogenic function of the ONC-Xmrk receptor.
  • To elucidate the mechanism by which these mutations lead to receptor activation and influence its processing.

Main Methods:

  • Construction and analysis of chimeric and mutant ONC-Xmrk receptors.
  • Investigation of mutations within both the intracellular and extracellular domains of the receptor.
  • Assessment of receptor dimerization, activation status, and endoplasmic reticulum processing, including glycosylation.

Main Results:

  • Mutations in the intracellular domain of ONC-Xmrk were not found to be responsible for receptor activation.
  • Two specific mutations in the extracellular domain were identified as critical for ONC-Xmrk activation: C578S (cysteine substitution) and G359R (glycine to arginine exchange in subdomain III).
  • Both identified mutations induce constitutive dimer formation, leading to receptor activation, and also impair receptor processing and glycosylation in the endoplasmic reticulum.

Conclusions:

  • The oncogenic function of ONC-Xmrk in Xiphophorus melanoma is driven by specific activating mutations in its extracellular domain.
  • These mutations promote constitutive dimerization and activation of the receptor tyrosine kinase, contributing to tumor development.
  • The identified mutations also impact receptor maturation, suggesting a link between altered processing and oncogenesis.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...